LDHA and neoplasm: Targeting LDHA through its knockdown in glycolysis presents a potential therapeutic strategy to curb MDSCs recruitment, alleviate immunosuppression, and enhance tumor immunogenicity via the autophagy-related mechanism and DOX-induced ICD effects.